ABBV vs MSFT
AbbVie Inc. vs Microsoft Corporation
ABBV
AbbVie Inc.
$220.75+0.32%
MSFT
Microsoft Corporation
$470.67-1.36%
Key Metrics Comparison
| ABBV | Metric | MSFT |
|---|---|---|
| $220.75 | Price | $470.67 |
| $390.11B | Market Cap | $3.50TBetter |
| 167.23 | P/E Ratio | 33.43Better |
| $1.32 | EPS | $14.08Better |
| +0.32%Better | Day Change | -1.36% |
| $244.81 | 52W High | $555.45 |
| $164.39 | 52W Low | $344.79 |
| 4,785,505 | Volume | 27,617,535Better |
| 5,788,224 | Avg Volume | 23,349,227Better |
About AbbVie Inc.
Healthcare | Drug Manufacturers - General
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...
About Microsoft Corporation
Technology | Software - Infrastructure
Microsoft Corporation develops, licenses, and supports software, services, devices, and solutions worldwide. The company operates in three segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment offers Office, Exc...